Metastases to liver – Life with Disease

Go back

Metastases to the liver represent cancer that has spread from another part of the body to the liver, creating a serious challenge for patients and their families. Understanding what lies ahead, how the disease may progress, and what daily life may look like can help patients and their loved ones prepare and make informed decisions about care and clinical trial participation.

Prognosis

When cancer spreads to the liver from another part of the body, the outlook depends on several important factors. The prognosis is deeply personal and varies from person to person based on the type of original cancer, how much the disease has spread, the location and number of tumors in the liver, and the person’s overall health before diagnosis.[1][3]

The liver is one of the most common sites where cancer spreads, accounting for nearly 25 percent of all metastatic cases.[3] This happens because the liver filters enormous amounts of blood every day—more than 250 gallons—which increases the chance that cancer cells traveling through the bloodstream will arrive and settle there.[6] Metastatic liver disease is actually much more common than cancer that starts in the liver itself.[1]

For patients with colorectal cancer that has spread to the liver, which is the most common type of liver metastasis, survival rates can vary widely. When cancer is limited to the liver and can be completely removed surgically, five-year survival rates can reach up to 40 percent.[12] However, only about 25 percent of patients with colorectal liver metastases are candidates for surgical removal.[12]

When cancer has spread beyond the liver to lymph nodes or other distant organs, survival times tend to be shorter. In one study of people with metastatic liver cancer, average survival ranged from 4 to 11 months depending on the severity of liver damage and whether treatment was received.[22] Relative five-year survival rates for liver cancer that has spread to nearby tissues or lymph nodes is approximately 11 percent.[22]

⚠️ Important
These survival numbers are averages from large groups of people and should not be seen as predictions for any individual. Your specific situation may be very different based on the characteristics of your cancer, which treatments you receive, how your body responds to treatment, and your overall health. New treatments are being developed continuously, and many patients live longer than average statistics suggest.

Natural Progression

Understanding how liver metastases develop and progress without treatment helps patients and families grasp the seriousness of the condition. Cancer cells that break away from the original tumor travel through the bloodstream or lymphatic system until they reach the liver.[4] Because the liver receives blood from many organs, especially the digestive system, it becomes a common destination for cancer cells looking for a new place to grow.

Once cancer cells arrive in the liver, they must survive and establish themselves. Different types of cells in the liver become involved in this process, including specialized immune cells called Kupffer cells, liver tissue cells called hepatocytes, and cells lining blood vessels.[4] The development of metastases happens in four phases: first, tiny blood vessels form; second, a pre-growth phase occurs; third, new blood vessels grow to feed the tumor; and fourth, the tumor begins to grow larger.[4]

Cancer can spread to any part of the liver. Sometimes only one metastasis appears, but most people develop multiple tumors in both sections, called lobes, of the liver.[1] The most common cancers that spread to the liver come from the colon and rectum, followed by the lungs, breast, pancreas, stomach, esophagus, and skin melanoma.[1][3]

If left untreated, metastatic liver disease progresses as tumors grow larger and more numerous. Nearly 20 to 25 percent of patients diagnosed with colorectal cancer will develop liver metastases during their illness, and about 15 to 25 percent already have liver involvement when the colorectal cancer is first discovered.[3] Death from colorectal cancer often results from liver metastases, with over half of patients dying from metastatic liver disease.[12]

Possible Complications

Liver metastases can lead to several serious complications that affect both health and daily functioning. As cancer grows in the liver, it interferes with the organ’s ability to perform its vital jobs, which include cleaning toxins from the blood, making proteins, helping digest fats, and storing energy.[5]

One significant complication occurs when cancer prevents the liver from properly removing toxins from the blood. This toxic buildup can cause hepatic encephalopathy, a serious condition that affects the brain and can lead to confusion, changes in personality, difficulty concentrating, and in severe cases, loss of consciousness.[6]

As tumors grow, they can block the normal flow of blood through the liver or obstruct the tubes that carry bile, a digestive fluid made by the liver. When bile cannot flow normally, it builds up and causes jaundice, which makes the skin and whites of the eyes turn yellow. Jaundice is often accompanied by dark-colored urine and very itchy skin.[1][5]

Fluid can accumulate in the abdomen, a condition called ascites, causing noticeable swelling and discomfort. The ankles may also swell.[1][5] These fluid buildups happen because the diseased liver cannot make enough proteins to keep fluid in the bloodstream where it belongs.

Pain in the upper right side of the abdomen, where the liver is located, can develop as the liver becomes enlarged and stretches its covering membrane. Some people also experience pain in the right shoulder.[5][6] The enlarged liver may be felt as a lump below the ribcage on the right side.[5]

Other complications include persistent fever, severe weight loss that continues despite efforts to eat, ongoing nausea and vomiting, and profound fatigue that doesn’t improve with rest.[1][5] These symptoms can significantly impact quality of life and may require specific interventions to manage.

Impact on Daily Life

Living with metastatic liver disease affects nearly every aspect of daily life, from physical abilities to emotional wellbeing, social relationships, work capacity, and personal interests. Understanding these impacts can help patients and families plan and seek appropriate support.

Physically, many patients experience profound fatigue that makes even simple tasks feel exhausting. This tiredness is different from normal fatigue because rest doesn’t fully relieve it.[1] Loss of appetite and unintended weight loss can lead to muscle weakness and decreased stamina, making it harder to maintain independence in daily activities.[1][5]

When symptoms like abdominal pain, nausea, or swelling develop, they can interfere with eating, sleeping, and moving comfortably. Jaundice and severe itching can be particularly distressing and may affect a person’s willingness to be around others.[1] Some patients find that their treatment schedule—which may include frequent hospital visits for chemotherapy, imaging tests, or procedures—takes up significant time and energy.

Emotionally, receiving a diagnosis of metastatic cancer is deeply challenging. Patients often experience fear, anxiety, sadness, and uncertainty about the future. These feelings are completely normal responses to a serious illness. Some people find it helpful to talk with mental health professionals, join support groups, or connect with others who have faced similar diagnoses.[16]

Social relationships may shift as the disease progresses. Some patients feel isolated or worry about being a burden to their loved ones. Others find that their relationships deepen as family and friends rally to provide support. Being open about needs and limitations can help maintain connections and ensure appropriate help is available.

Work life is often affected, especially if treatment causes fatigue or requires frequent medical appointments. Some patients continue working with modifications, while others need to reduce hours or stop working entirely. Understanding workplace rights and available disability benefits can ease financial concerns during this transition.

Hobbies and activities that once brought joy may become difficult or impossible due to physical limitations or treatment schedules. Finding new, less physically demanding activities or adapting favorite pastimes can help maintain a sense of purpose and enjoyment. Some patients discover new interests that fit their current abilities.

⚠️ Important
Quality of life remains a priority throughout treatment. Many healthcare teams include specialists who focus specifically on managing symptoms and supporting emotional wellbeing. Don’t hesitate to tell your medical team about any symptoms or concerns affecting your daily life—many can be addressed with medications, therapies, or supportive services.

Support for Family

Family members and caregivers play a crucial role when a loved one has metastatic liver disease. Understanding clinical trials and how to support participation in research can open doors to potentially beneficial treatments while contributing to medical knowledge that may help others in the future.

Clinical trials are research studies that test new treatments, combinations of treatments, or new ways of using existing treatments. For metastatic liver disease, clinical trials may investigate novel chemotherapy drugs, targeted therapies that attack specific cancer characteristics, immunotherapy approaches that help the body’s immune system fight cancer, or procedures like ablation techniques that destroy tumors.[7]

Families should know that participation in a clinical trial is always voluntary. Patients can leave a trial at any time if they change their mind or if the treatment is too difficult to tolerate. Not all patients qualify for every trial—researchers establish specific criteria based on the type of cancer, extent of disease, previous treatments, and overall health.[16]

To help a loved one explore clinical trial options, families can start by asking the oncology team about available trials. Many cancer centers have research coordinators who specialize in matching patients with appropriate studies. Online databases also list ongoing clinical trials, though understanding eligibility requirements may require professional guidance.

When considering a clinical trial, families can help by attending appointments, taking notes, and asking questions. Important questions include: What is the purpose of this trial? What treatments are being tested? What are the possible benefits and risks? How does participation in a trial differ from standard treatment? What additional appointments or tests will be required? Will travel or accommodation be needed?

Practical support matters tremendously. Families can assist with transportation to and from appointments, help manage medication schedules, keep track of symptoms or side effects to report to the medical team, prepare meals when appetite is poor, and handle household tasks that become overwhelming for the patient.

Emotional support is equally important. Simply being present, listening without judgment, and acknowledging the difficulty of the situation can provide comfort. Respecting the patient’s wishes about treatment decisions, even when family members might choose differently, honors their autonomy and dignity.

Caregivers must also care for themselves. Watching a loved one face serious illness is emotionally and physically draining. Seeking support from other family members, friends, support groups, or professional counselors can help caregivers maintain their own wellbeing, which ultimately enables them to provide better care.

Financial concerns often arise during serious illness. Families can help by researching insurance coverage, investigating financial assistance programs offered by pharmaceutical companies or nonprofit organizations, and connecting with hospital social workers who specialize in identifying resources for patients facing financial hardship.

Finally, families should remember that they are part of the healthcare team. Their observations about changes in the patient’s condition, their questions about treatment, and their advocacy for the patient’s needs and preferences all contribute to better care. Open communication with the medical team creates partnerships that benefit everyone involved.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Sorafenib – A multikinase inhibitor that targets and blocks proteins signaling liver tumors to grow or form blood vessels feeding the tumor
  • Regorafenib – A multikinase inhibitor that targets and blocks proteins signaling liver tumors to grow or form blood vessels feeding the tumor
  • Bevacizumab – Decreases blood supply to tumors, used to treat colon cancer that has spread to the liver
  • Cetuximab – Can slow tumor growth, used to treat colon cancer that has spread to the liver
  • Nivolumab – An anti-PD1 inhibitor immunotherapy drug that helps accelerate the immune system’s response to shrink liver cancer or slow its growth

Ongoing Clinical Trials on Metastases to liver

  • Study on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France
  • Study on Preoperative Immunotherapy with Atezolizumab and Tiragolumab for Patients with Colorectal Liver Metastases

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Treatment for Colorectal Liver Metastases Using Heparin, Dexamethasone, and Floxuridine for Patients with Heavy Tumor Burden

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Norway

References

https://cancer.ca/en/cancer-information/cancer-types/metastatic/liver-metastases

https://www.mskcc.org/cancer-care/types/liver-metastases

https://www.ncbi.nlm.nih.gov/books/NBK553118/

https://en.wikipedia.org/wiki/Liver_metastasis

https://www.healthline.com/health/liver-metastases

https://my.clevelandclinic.org/health/diseases/metastatic-liver-cancer

https://www.mskcc.org/cancer-care/types/liver-metastases/treatment

https://www.cancer.org/cancer/supportive-care/advanced-cancer/liver-metastases.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC8479345/

https://www.cancerresearchuk.org/about-cancer/secondary-cancer/secondary-liver-cancer/treatment

https://hpbsurgery.ucsf.edu/condition/liver-metastases

https://pmc.ncbi.nlm.nih.gov/articles/PMC4611310/

https://surgery.ucsf.edu/condition/liver-metastases

https://nyulangone.org/conditions/liver-cancer-liver-metastases/treatments/targeted-therapies-for-liver-cancer-liver-metastases

https://cancer.ca/en/cancer-information/cancer-types/metastatic/liver-metastases

https://pmc.ncbi.nlm.nih.gov/articles/PMC5701682/

https://cancer.ca/en/cancer-information/cancer-types/metastatic/liver-metastases

https://www.cancer.org/cancer/supportive-care/advanced-cancer/liver-metastases.html

https://www.cancerresearchuk.org/about-cancer/secondary-cancer/secondary-liver-cancer/treatment

https://www.kolhapurcancercentre.com/blog/can-you-survive-metastatic-liver-cancer/

https://www.mskcc.org/cancer-care/types/liver-metastases/treatment/follow

https://www.healthline.com/health/cancer/stages-of-metastatic-liver-cancer

FAQ

What’s the difference between primary liver cancer and metastatic liver cancer?

Primary liver cancer starts in the liver itself, while metastatic liver cancer (or liver metastases) means cancer that started somewhere else in the body—like the colon, breast, or lungs—has spread to the liver. The cancer cells in metastatic liver disease are not liver cells but cells from the original cancer site. Metastatic liver cancer is much more common than primary liver cancer.

Why does cancer spread to the liver so often?

The liver’s role in filtering blood makes it particularly vulnerable to cancer spread. It filters more than 250 gallons of blood daily, receiving blood from many organs, especially the digestive system through the portal vein. This rich blood supply increases the chance that cancer cells traveling through the bloodstream will reach and settle in the liver.

What are the early warning signs of liver metastases?

Early on, liver metastases may not cause any symptoms because the liver is large and can function normally even with cancer present. As the disease progresses, common symptoms include persistent fatigue, loss of appetite, unintended weight loss, nausea, abdominal pain or swelling (especially in the upper right area), jaundice (yellowing of skin and eyes), dark urine, and fever. If you notice these symptoms, especially if they’re worsening, see your doctor.

Can liver metastases be cured?

For some patients, particularly those with colorectal cancer that has spread only to the liver in limited amounts, surgical removal of all visible tumors can lead to long-term survival—up to 40% of these patients survive five years or more. However, only about 25% of patients with liver metastases are candidates for this surgery. For others, treatment focuses on controlling the disease and managing symptoms rather than cure.

How are liver metastases diagnosed?

Diagnosis typically involves blood tests (including liver function tests and tumor markers), imaging tests like CT scans, MRI, ultrasound, or PET scans, and sometimes a liver biopsy where a small tissue sample is removed and examined. The biopsy can identify what type of cancer has spread to the liver, which helps doctors plan the most appropriate treatment.

🎯 Key takeaways

  • Metastatic liver cancer is 20 times more common than cancer that starts in the liver itself
  • The liver’s daily filtering of 250+ gallons of blood makes it especially vulnerable to cancer spread
  • Early symptoms may be absent because the liver can function normally even with cancer present
  • About 25% of colorectal cancer patients with liver metastases may be candidates for potentially curative surgery
  • Five-year survival rates after complete surgical removal can reach 40% for selected patients
  • New targeted therapies and immunotherapies are opening doors for patients not eligible for surgery
  • Clinical trials offer access to cutting-edge treatments and contribute to medical knowledge for future patients
  • Family support and caregiver involvement are crucial components of successful treatment and quality of life